Medartis Holding AG (XSWX:MED) EBIT: CHF20.3 Mil (TTM As of Dec. 2025)


XSWX:MED Medartis Holding AG XSWX:MED
76 GF Score
Price CHF72.00
GF Value CHF105.61
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG EBIT?

Medartis Holding AG XSWX:MED -0.55% 76 EBIT is CHF20.3 Mil as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.61 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Medartis Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was CHF10.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF20.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medartis Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 was -2.76%. Medartis Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 11.41%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medartis Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.99%.


Medartis Holding AG  (XSWX:MED) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medartis Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-12.744 * ( 1 - 12.7% )/( (315.982 + 491.097)/ 2 )
=-11.125512/403.5395
=-2.76 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=465.703 - 29.212 - ( 120.509 - max(0, 49.893 - 264.772+120.509))
=315.982

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Medartis Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=20.442/( ( (77.94 + max(94.703, 0)) + (94.059 + max(91.681, 0)) )/ 2 )
=20.442/( ( 172.643 + 185.74 )/ 2 )
=20.442/179.1915
=11.41 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(46.098 + 86.855 + 3.542) - (29.212 + 0 + 12.58)
=94.703

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(50.337 + 98.198 + 5.141) - (35.859 + 0 + 26.136)
=91.681

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medartis Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=20.265/1020.898
=1.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG EBIT Related Terms


Medartis Holding AG EBIT Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG EBIT Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.04 -6.41 2.62 7.88 20.27

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 5.50 2.38 10.04 10.22

XSWX:MED vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Medartis Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's EV-to-EBIT falls into.


XSWX:MED
76GF Score
Medartis Holding AG XSWX:MED
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF20.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of CHF20.3 Mil mean?
Medartis Holding AG (XSWX:MED) has a EBIT of CHF20.3 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medartis Holding AG.
Is Medartis Holding AG's EBIT too high?
Medartis Holding AG's current EBIT is CHF20.3 Mil. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's EBIT compare to ABT and SYK?
Medartis Holding AG's EBIT of CHF20.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medartis Holding AG. Medartis Holding AG's current EBIT is CHF20.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF105.61, compared to a current price of CHF72.00 — trading 31.8% below its estimated fair value. The current EBIT is CHF20.3 Mil. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current EBIT is CHF20.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF72.00 is trading 31.8% below its estimated GF Value™ of CHF105.61. GuruFocus considers Medartis Holding AG to be Significantly Undervalued.

Key valuation signals for XSWX:MED:

  • EBIT: CHF20.3 Mil
  • GF Value™: CHF105.61 vs. price of CHF72.00 (31.8% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score

Get the complete analysis for XSWX:MED

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF72.00
Price
CHF105.61
GF Value